findmyKOL

Mathew Hutchinson, MD

Basic profile

Banner - University Medical Center Tucson

ORCIDNPI
RegionTucson, AZ · WestSpecialtyClinical Cardiac ElectrophysiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2017Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Mathew Hutchinson is a Cardiology physician affiliated with Banner - University Medical Center Tucson. OpenAlex indexes 189 publications with 9,487 citations (h-index 53); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Clinical Cardiac Electrophysiology profiles in the findmyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
189publications

Distinct works indexed by OpenAlex, matched via ORCID.

9,487citations

Total citations across indexed works.

53h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials
11companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1625 N Campbell Avenue
Tucson, AZ 857244306

Telephone

520-874-3457

Provider last certified this registry record 12 Dec 2025.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    63.2%
    Beta blocker30.8%
    Metoprolol Succinate54%Sotalol46%
    Part D26 patients
    Antiarrhythmic27.8%
    Flecainide Acetate52%Amiodarone Hcl48%
    Part D26 patients

    + 1 more class in this area

  • Blood & clotting

    30.8%
    Factor Xa inhibitor23.2%
    Eliquis79%Xarelto21%
    Part D<11 patients
    P2Y12 inhibitor7.6%
    Clopidogrel100%
    Part D13 patients
  • Metabolism & gastrointestinal

    6%
    Potassium supplement6%
    Potassium Chloride100%
    Part D<11 patients
Where care is delivered (Part B)35.6% facility · 64.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”